Differential iNKT and T Cells Activation in Non-Alcoholic Fatty Liver Disease and Drug-Induced Liver Injury.
Estefanía Caballano-InfantesAlberto García-GarcíaCarlos Lopez-GomezAlejandro CuetoMercedes Robles-DiazAida Ortega-AlonsoFlores Martín-ReyesIsmael Alvarez-AlvarezIsabel Arranz-SalasFrancisco Ruiz-CabelloMaría Isabel LucenaEduardo Garcia-FuentesRaúl Jesús AndradeMiren García-CortésPublished in: Biomedicines (2021)
CD69+iNKT may be a biomarker to assess liver fibrosis progression in NAFLD. CD69+CD8+ T cells were identified as a potential distinctive biomarker for distinguishing DILI from NAFLD.